GPCR (Structure Therapeutics Inc.) Stock Financials & Earnings

GPCRStructure Therapeutics Inc.

Mkt Cap$3B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$141M

EPS (TTM)-$2.40

Free Cash Flow (TTM)-$226M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$20M
Q2 23	$0	$0	-$26M
Q3 23	$0	$0	-$26M
Q4 23	$0	$0	-$31M
Q1 24	$0	$0	-$32M
Q2 24	$0	$0	-$33M
Q3 24	$0	$0	-$46M
Q4 24	$0	$0	-$47M
Q1 25	$0	$0	-$56M
Q2 25	$0	$0	-$70M
Q3 25	$0	$0	-$74M
Q4 25	$0	$0	$24M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$126M	$114M	$241M
Q2 23	$41M	$184M	$225M
Q3 23	$51M	$155M	$205M
Q4 23	$130M	$338M	$467M
Q1 24	$98M	$339M	$436M
Q2 24	$382M	$545M	$927M
Q3 24	$172M	$743M	$915M
Q4 24	$170M	$714M	$884M
Q1 25	$152M	$685M	$837M
Q2 25	$147M	$639M	$786M
Q3 25	$103M	$696M	$799M
Q4 25	$800M	$647M	$1.4B

Shares Outstanding

Revenue Per Employee

Revenue / Employee